[
  {
    "ts": null,
    "headline": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=6907dbae759554293e23db8e581b7539e33b15385a107b8e807348c920102e56",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754398806,
      "headline": "AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know",
      "id": 136214904,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=6907dbae759554293e23db8e581b7539e33b15385a107b8e807348c920102e56"
    }
  },
  {
    "ts": null,
    "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
    "summary": "The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.",
    "url": "https://finnhub.io/api/news?id=aff8fb04ed2b55aa72830d4b61a520fd2e4374df30428b78158e4b56640b2fa6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754398803,
      "headline": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar",
      "id": 136214905,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.",
      "url": "https://finnhub.io/api/news?id=aff8fb04ed2b55aa72830d4b61a520fd2e4374df30428b78158e4b56640b2fa6"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Stock Outlook: Is Wall Street Bullish or Bearish?",
    "summary": "Despite AbbVie’s underperformance relative to the S&P 500 over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=4449cb144caab9c95b2288aa92eda9329291b02e628c1ede33d444e36b579964",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754398639,
      "headline": "AbbVie Stock Outlook: Is Wall Street Bullish or Bearish?",
      "id": 136212244,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Despite AbbVie’s underperformance relative to the S&P 500 over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=4449cb144caab9c95b2288aa92eda9329291b02e628c1ede33d444e36b579964"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags",
    "summary": "NYSE:ABBV 1 Year Share Price vs Fair Value Explore AbbVie's Fair Values from the Community and select yours AbbVie...",
    "url": "https://finnhub.io/api/news?id=7d4d19aed628f3f7861001786192cdc58e66225e5851f955d6b0104b403ef251",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754397502,
      "headline": "AbbVie Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags",
      "id": 136212245,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "NYSE:ABBV 1 Year Share Price vs Fair Value Explore AbbVie's Fair Values from the Community and select yours AbbVie...",
      "url": "https://finnhub.io/api/news?id=7d4d19aed628f3f7861001786192cdc58e66225e5851f955d6b0104b403ef251"
    }
  },
  {
    "ts": null,
    "headline": "Allergan Aesthetics Unveils the New Faces of Natrelle® and Real Stories of Empowerment and Transparency",
    "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is launching its Faces of Natrelle® campaign – a powerful tribute to resilience and authenticity. The campaign features nine inspiring women who openly share their breast augmentation and reconstruction journeys with Natrelle® breast implants, aiming to reshape the narrative around breast procedures through real, relatable stories.",
    "url": "https://finnhub.io/api/news?id=e7960c3d173ceb057ed01fc09e766d34cac9905c6fa82432936cda6742015e98",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754395200,
      "headline": "Allergan Aesthetics Unveils the New Faces of Natrelle® and Real Stories of Empowerment and Transparency",
      "id": 136212246,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is launching its Faces of Natrelle® campaign – a powerful tribute to resilience and authenticity. The campaign features nine inspiring women who openly share their breast augmentation and reconstruction journeys with Natrelle® breast implants, aiming to reshape the narrative around breast procedures through real, relatable stories.",
      "url": "https://finnhub.io/api/news?id=e7960c3d173ceb057ed01fc09e766d34cac9905c6fa82432936cda6742015e98"
    }
  },
  {
    "ts": null,
    "headline": "COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS",
    "summary": "CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aesthetics, today announced that it will report financial results for the second quarter on Wednesday, August 20, 2025, before the opening of the U.S. financial markets.",
    "url": "https://finnhub.io/api/news?id=721c351a18a3a4aa2b2af72c775c826c49ac373fb1d95b1fa7d739caaec7da81",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754391600,
      "headline": "COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS",
      "id": 136212247,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aesthetics, today announced that it will report financial results for the second quarter on Wednesday, August 20, 2025, before the opening of the U.S. financial markets.",
      "url": "https://finnhub.io/api/news?id=721c351a18a3a4aa2b2af72c775c826c49ac373fb1d95b1fa7d739caaec7da81"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary",
    "summary": "Janus Henderson Global Life Sciences Diversified ADR Managed Account returned -3.68% (gross) and the MSCI World Health Care Index returned -3.96%. Read more here.",
    "url": "https://finnhub.io/api/news?id=43278605299a51388bd3eed265ac982c872aaf1763e0851ee415ae42adb8f45e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754374920,
      "headline": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary",
      "id": 136207822,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171573445/image_171573445.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Janus Henderson Global Life Sciences Diversified ADR Managed Account returned -3.68% (gross) and the MSCI World Health Care Index returned -3.96%. Read more here.",
      "url": "https://finnhub.io/api/news?id=43278605299a51388bd3eed265ac982c872aaf1763e0851ee415ae42adb8f45e"
    }
  }
]